Pluronic L61 Accelerates Flip–Flop and Transbilayer Doxorubicin Permeation
It has recently been found that Pluronics (block copolymers of ethylene oxide, EO, and propylene oxide, PO) favor the permeability and accumulation of anthracycline antibiotics, for example doxorubicin (Dox), in tumor cells. In an effort to understand these results, the interaction of EO2/PO32/EO2 (Pluronic L61) with unilamellar egg yolk vesicles (80–100 nm in diameter) was examined. A partition coefficient Kp=[Pl]membrane/[Pl]water=45 was determined. This corresponds to adsorption of about 20 polymer molecules to the surface of each vesicle in a 20 μM polymer solution. Despite this rather weak adsorption, Pluronic has a substantial effect upon the transmembrane permeation rate of Dox and upon the phospholipid flip–flop rate within the bilayers. Thus, the Dox permeation rate increases threefold and the flip–flop rate increases sixfold in 20 μM Pluronic. The two rates increase linearly with the amount of adsorbed polymer. The obvious ability of Pluronics to increase the mobility of membrane components may have important biomedical consequences.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Langmuir
6 publications, 11.11%
|
|
|
Polymer Science - Series A
3 publications, 5.56%
|
|
|
Biomacromolecules
3 publications, 5.56%
|
|
|
Journal of Drug Delivery Science and Technology
2 publications, 3.7%
|
|
|
Molecular Therapy - Methods and Clinical Development
2 publications, 3.7%
|
|
|
Biochimica et Biophysica Acta - Biomembranes
2 publications, 3.7%
|
|
|
A Tribute to Marin D. Mitov
1 publication, 1.85%
|
|
|
NATO Science for Peace and Security Series B: Physics and Biophysics
1 publication, 1.85%
|
|
|
Journal of Applied Polymer Science
1 publication, 1.85%
|
|
|
Biochimica et Biophysica Acta (BBA) - Biomembranes
1 publication, 1.85%
|
|
|
Biochemistry
1 publication, 1.85%
|
|
|
ACS Applied Polymer Materials
1 publication, 1.85%
|
|
|
Biointerphases
1 publication, 1.85%
|
|
|
Human Gene Therapy
1 publication, 1.85%
|
|
|
Experimental Biology and Medicine
1 publication, 1.85%
|
|
|
Colloid and Polymer Science
1 publication, 1.85%
|
|
|
AAPS PharmSciTech
1 publication, 1.85%
|
|
|
European Physical Journal E
1 publication, 1.85%
|
|
|
PLoS ONE
1 publication, 1.85%
|
|
|
Journal of Controlled Release
1 publication, 1.85%
|
|
|
European Polymer Journal
1 publication, 1.85%
|
|
|
Journal of Colloid and Interface Science
1 publication, 1.85%
|
|
|
Chemical Physics Letters
1 publication, 1.85%
|
|
|
Biomaterials
1 publication, 1.85%
|
|
|
Biotechnology and Applied Biochemistry
1 publication, 1.85%
|
|
|
Advanced Functional Materials
1 publication, 1.85%
|
|
|
FEBS Journal
1 publication, 1.85%
|
|
|
Journal of Gene Medicine
1 publication, 1.85%
|
|
|
Journal of Physical Chemistry B
1 publication, 1.85%
|
|
|
1
2
3
4
5
6
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
16 publications, 29.63%
|
|
|
American Chemical Society (ACS)
15 publications, 27.78%
|
|
|
Springer Nature
5 publications, 9.26%
|
|
|
Wiley
5 publications, 9.26%
|
|
|
Pleiades Publishing
4 publications, 7.41%
|
|
|
Walter de Gruyter
2 publications, 3.7%
|
|
|
American Vacuum Society
1 publication, 1.85%
|
|
|
Mary Ann Liebert
1 publication, 1.85%
|
|
|
SAGE
1 publication, 1.85%
|
|
|
Public Library of Science (PLoS)
1 publication, 1.85%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 1.85%
|
|
|
Center of Pharmaceutical Analytics Ltd
1 publication, 1.85%
|
|
|
The Russian Academy of Sciences
1 publication, 1.85%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.